It's not much but I am liking this posters thinking (where is CEOA1) when talking about what could happen when we list in the US, same thoughts I have with the fact that the yanks won't be caring about what was but will be looking at what is and what will be:
"HS from what I understand they are going to be listed on a major US exchange around the end of the year. The shares that are traded on the pinks aren't really US shares, but the actual aussie shares. I think the pullback was basically some profit taking and the way these aussie trade, the stock runs up a bit, then they dump. Long term holders are really an anomaly over there. There also is little to no institutional support. Those are some of the reasons they are going to list here in the US. Any of the big healthcare funds can buy enough of this stock to triple the price and it still wouldn't be a big position for them. There is very little risk in this right now because of the backing of Sanofi. Now they will have a product soon to be released and sometime next year they'll be in a position to begin supplying sanofi. That's remarkable. I can see after the US listing that this stock could be a 10 bagger in two years or less. I'm talking for the point of listing, forget where its trading right now."
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)